Related Experiment Videos
Roche splashes $2.4 billion on Foundation Medicine's cancer platform
Nature Biotechnology
|September 7, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Proteome-wide identification of the druggable CRBN interactome.
Nature biotechnology·2026
Discovery and design of potent cell surface display elements.
Nature biotechnology·2026
Mechanistic machine learning for prediction of prime editing outcomes.
Nature biotechnology·2026
The Contemporary Pattern of Radical Cystectomy in the Treatment of High-Grade Non-Muscle Invasive Bladder Cancer.
Clinical genitourinary cancer·2026
Preparation for parathyroid surgery.
Journal of visceral surgery·2026
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Toxicity of Cytarabine Intravenous Constant Rate Infusion in Cats With Lymphoma.
Veterinary and comparative oncology·2026
Extraocular muscle and orbital fat changes in treatment of thyroid eye disease with monoclonal antibodies: a systematic review and meta-analysis.
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026
Conformational switching of Trp399 regulates opening and closing of loop-1 in galactofuranosyl transferase 2 of Mycobacterium tuberculosis.
International journal of biological macromolecules·2026